skip to main content

    Updated Visitor Guidelines

 

MENU

 

Prevention, Preparedness and Progress Podcasts

the 3 Ps of Cancer Podcasts

Each episode tackles one of these areas of focus with topics presented by University of Michigan Rogel Cancer Center physicians, staff or patients.

What is Treated

CAR T-cell Therapy has been approved by the U.S. Food and Drug Administration for:

Frequently Asked Questions About CAR T-cell Therapy

What is CAR T-cell therapy?

CAR T-cell is a type of cellular therapy. We take immune cells out of a patient’s body, and then we modify these cells so that they can target and kill cancer cells. Then we reinfuse these cells into the patient. The cells go into the patient, find their target on the cancer cell surface and kill those cells.

Dlugosz to oversee basic science research at Rogel Cancer Center

The University of Michigan Rogel Cancer Center has named Andrzej Dlugosz, M.D., associate director for basic science research. He currently co-leads the Rogel Cancer Center’s cancer biology program. In his new role, Dlugosz will oversee the Rogel Cancer Center’s four basic science research programs.

An Interactive Website Boosts Genetic Testing Knowledge in Breast Cancer Patients

A team at the University of Michigan Rogel Cancer Center recently sought to determine how much newly diagnosed cancer patients understand about the benefits of genetic testing after a diagnosis. Their other objective: to find out whether a decision support tool would help improve that knowledge.

Pages